Skip to main content
. Author manuscript; available in PMC: 2011 Jul 26.
Published in final edited form as: Biomarkers. 2011 Feb 8;16(2):172–180. doi: 10.3109/1354750X.2010.541564

Table 1.

Diagnostic description of the control patients for the different tumor types are shown.

Tissue type Tissue Type
Renal Pancreas
Adenoma Microcystic serous adenoma
Cystadenoma Mucinous cystadenoma
Cystic nephroma Chronic pancreatits
Mesenteric cyst Fibrosis
Adenoma Serous oligocystic adenoma
Benign cyst No malignancy found
Atrophy Atrophy
Nodular hyperplasia Microcystic serous
Ganglioneuroma cyst adenoma
Cortical adenoma Adenoma
Mucinous cystic neoplasm
Cystadenoma
Ulcer
Tubular adenoma
Cystic neoplasm
Colon Mucinous cystadenoma
Adenoma Serous cystadenoma
Fibrosis
Diverticulosis
Fibrosis
Dysplasia
Chronic inflammation
No pathological diagnosis
Breast Prostate
Breast Reduction Negative for tumor
No pathological Diagnosis Reactive lymphoid Hyperplasia
Fibrosis Negative for malignancy
Intraductal Papilloma
Lung Liver
Nodules (non-cancerous) Hemangioma
Caseating granuloma Calcified granuloma
Granulomatous inflammation Fibrosis
Fungal Bronchropneumonia Nodular Hyperplasia
Fibrosis Bile duct hamartoma
Emphysema Inflammation
No malignancy found Endometrosis with hyperplasia
Interstitial lung disease Fatty Infiltration
No tumor identified Mucinous cystadenoma
Caseating granuloma Cavernous hemangioma
Hyperplasia Focal hyperplasia
Interstitial fibrosis Negative for tumor
Hamartoma Hepatocellular adenoma
Granduloma Solitary cyst
Cystadenoma
Bile duct proliferation